Logo image of AUS

AUSTERLITZ ACQUISITION COR-A (AUS) Stock Fundamental Analysis

NYSE:AUS - New York Stock Exchange, Inc. - KYG0633D1097 - Common Stock - Currency: USD

9.98  0 (0%)

Fundamental Rating

2

Taking everything into account, AUS scores 2 out of 10 in our fundamental rating. AUS was compared to 0 industry peers in the Unkown industry. AUS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AUS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AUS was profitable.
AUS had a positive operating cash flow in the past year.
AUS Yearly Net Income VS EBIT VS OCF VS FCFAUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 7.56%
ROE 7.84%
ROIC 0.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AUS Yearly ROA, ROE, ROICAUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 20 40 60 80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AUS Yearly Profit, Operating, Gross MarginsAUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, AUS has more shares outstanding
There is no outstanding debt for AUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AUS Yearly Shares OutstandingAUS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 20M 40M 60M 80M
AUS Yearly Total Debt VS Total AssetsAUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 200M 400M 600M

2.2 Solvency

AUS has an Altman-Z score of 23.81. This indicates that AUS is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for AUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 23.81
ROIC/WACCN/A
WACCN/A
AUS Yearly LT Debt VS Equity VS FCFAUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.83 indicates that AUS has no problem at all paying its short term obligations.
AUS has a Quick Ratio of 2.83. This indicates that AUS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.83
AUS Yearly Current Assets VS Current LiabilitesAUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

AUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103567.14%, which is quite impressive.
EPS 1Y (TTM)103567.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.83 indicates a rather expensive valuation of AUS.
AUS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.83
Fwd PE N/A
AUS Price Earnings VS Forward Price EarningsAUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 1304.68
EV/EBITDA N/A
AUS Per share dataAUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AUS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUSTERLITZ ACQUISITION COR-A

NYSE:AUS (11/22/2022, 8:04:01 PM)

9.98

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.66%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap983.74M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.83
Fwd PE N/A
P/S N/A
P/FCF 1304.68
P/OCF 1304.68
P/B 1.48
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)0.53
EY5.31%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY0.08%
OCF(TTM)0.01
OCFY0.08%
SpS0
BVpS6.77
TBVpS6.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.56%
ROE 7.84%
ROCE N/A
ROIC 0.07%
ROICexc 0.07%
ROICexgc 0.07%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 1.44%
Current Ratio 2.83
Quick Ratio 2.83
Altman-Z 23.81
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103567.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17096%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A